AKCA
Akcea Therapeutics Inc
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
56 hedge funds and large institutions have $541M invested in Akcea Therapeutics Inc in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
56
Holding in Top 10
–
Calls
$3.19M
Puts
$2.42M
Top Buyers
| 1 | +$58M | |
| 2 | +$7.84M | |
| 3 | +$2.92M | |
| 4 |
BlackRock
New York
|
+$2.87M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$2.24M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$4.48M | |
| 3 | -$2.49M | |
| 4 |
Jane Street
New York
|
-$524K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$383K |